Author Question: If the mean square between-groups is the same as the mean square within-groups, then A) the ... (Read 42 times)

naturalchemist

  • Hero Member
  • *****
  • Posts: 542
If the mean square between-groups is the same as the mean square within-groups, then
 
  A) the F-ratio will be approximately 1.00.
  B) the experimental manipulations had large effects.
  C) the differences between experimental conditions are greater than by chance alone.
  D) the F-ratio will be very large.

Question 2

The F-ratio can be made larger
 
  A) only by increasing the between-groups mean square.
  B) only by increasing the within-groups mean square.
  C) by increasing the within-groups mean square or by decreasing the between-groups mean square.
  D) by increasing the between-groups mean square or by decreasing the within-groups mean square.



Bsand8

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

Answer: A

Answer to Question 2

Answer: D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

naturalchemist

  • Hero Member
  • *****
  • Posts: 542
Both answers were spot on, thank you once again



Bsand8

  • Sr. Member
  • ****
  • Posts: 327

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library